Moreover, DNMT inhibition triggers antiviral defense mechanisms in both tumor and immune cells, boosting type I interferon signaling, remodeling the suppressive immune environment, and enhancing the efficacy of immune checkpoint blockade [177]. The gene discussed is DNMT1; the disease is neoplasm.